Open AccessThe impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis
Author(s) -
Marta C. Nunes,
Anne von Gottberg,
Linda de Gouveia,
Cheryl Cohen,
David P. Moore,
Keith P. Klugman,
Shabir А. Madhi
Publication year - 2011
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328341b7f1
Subject(s) - medicine , pneumococcal conjugate vaccine , pediatrics , incidence (geometry) , meningitis , bacteremia , pneumococcal infections , confidence interval , streptococcus pneumoniae , immunology , antibiotics , physics , optics , microbiology and biotechnology , biology
HIV infection is a major risk factor for invasive pneumococcal disease (IPD). A national antiretroviral program was initiated in South Africa in 2004. This study evaluates the impact of the highly active antiretroviral therapy (HAART) treatment program on the burden of IPD among African children.